Medicare Enrolled

Dr. Yun Ying Shi, MD

Endocrinology · Burlingame, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1750 EL CAMINO REAL, Burlingame, CA 94010
6506929751
In practice since 2013 (12 years)
NPI: 1861833899 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Shi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Shi

Dr. Yun Ying Shi is an endocrinology specialist in Burlingame, CA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Shi performed 5,133 Medicare services across 830 unique beneficiaries.

Between the years covered by Open Payments, Dr. Shi received a total of $14,227 from 36 pharmaceutical and/or device companies across 699 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Shi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice ▲ Top 16% volume in CA $14,227 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,133
Medicare services
Top 16% in CA for endocrinology
830
Unique beneficiaries
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~428 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 3,300 $18 $35
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
981 $106 $250
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
327 $156 $375
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
179 $30 $120
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
109 $14 $65
New patient office visit, complex (60-74 min) 83 $191 $450
Prolonged office E/M service, first 15 minutes
This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service.
55 $29 $120
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
38 $67 $165
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
36 $53 $120
Continuous glucose monitoring, sensor under skin
This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment.
25 $159 $475
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$14,227
Total received (2018-2024)
Avg $2,032/year across 7 years
Top 15% in CA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
699
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,227 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,617
2023
$1,691
2022
$1,022
2021
$1,749
2020
$1,738
2019
$3,084
2018
$3,324

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$351
Novo Nordisk Inc
$210
Amgen Inc.
$158
Boehringer Ingelheim Pharmaceuticals, Inc.
$108
Dexcom, Inc.
$102
Abbott Laboratories
$96
Novartis Pharmaceuticals Corporation
$90
Theratechnologies Inc.
$79
Alexion Pharmaceuticals, Inc.
$63
AstraZeneca Pharmaceuticals LP
$59
Ultragenyx Pharmaceutical Inc.
$57
Radius Health, Inc.
$47
Xeris Pharmaceuticals, Inc.
$47
Kyowa Kirin, Inc.
$27
Verity Pharmaceuticals Inc.
$26
Corcept Therapeutics
$26
RGH Enterprises LLC
$25
Mannkind Corporation
$25
VIVUS LLC
$22
Top 3 companies account for 44.5% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$2,956
Amgen Inc.
$2,051
Lilly USA, LLC
$1,992
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,241
AstraZeneca Pharmaceuticals LP
$670
Insulet Corporation
$612
SANOFI-AVENTIS U.S. LLC
$584
Mannkind Corporation
$372
Merck Sharp & Dohme Corporation
$367
Dexcom, Inc.
$359
Abbott Laboratories
$301
MannKind Corporation
$257
Novartis Pharmaceuticals Corporation
$245
Alexion Pharmaceuticals, Inc.
$237
Janssen Pharmaceuticals, Inc
$201
Corcept Therapeutics
$192
Radius Health, Inc.
$179
Eli Lilly and Company
$173
Regeneron Healthcare Solutions, Inc.
$161
Xeris Pharmaceuticals, Inc.
$140
Medtronic MiniMed, Inc.
$137
AbbVie, Inc.
$125
Senseonics, Incorporated
$112
AbbVie Inc.
$81
Theratechnologies Inc.
$79
Ultragenyx Pharmaceutical Inc.
$71
Shire North American Group Inc
$68
VIVUS, Inc.
$60
IBSA Pharma Inc.
$39
Kyowa Kirin, Inc.
$27
Verity Pharmaceuticals Inc.
$26
RGH Enterprises LLC
$25
Amarin Pharma Inc.
$23
Bayer Healthcare Pharmaceuticals Inc.
$22
VIVUS LLC
$22
Astellas Pharma US Inc
$21
Top 3 companies account for 49.2% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BASAGLAR · Crysvita · Dexcom CGM · Dexcom G6 Transmitter · EGRIFTA · EVENITY · Eversense · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre Pro · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · HUMULIN R 500 · INVOKANA · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LYUMJEV · MOUNJARO · MULTAQ · MiniLink Real-Time Transmitter · Minimed 630G · Minimed 670G System · NATPARA · NATPARA (PARATHYROID HORMONE) · Omnipod · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Prolia · QSYMIA · RECORLEV · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · STEGLUJAN · STRENSIQ · SYNJARDY · SYNTHROID · Saxenda · Strensiq · Synthroid · TAVNEOS · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · Tirosint · Tlando · Tresiba · Tymlos · Vascepa · Veozah · Victoza · Wegovy · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Burlingame?
Compare endocrinologists in the Burlingame area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
117
Per 100K population
15.7
County median income
$156,000
Nearest hospital
PENINSULA MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Shi is a clinical cardiology specialist, with above-average Medicare volume (top 16% in CA), with low-engagement industry engagement in the top 15% of CA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Shi experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Shi performed 3,300 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shi receive payments from pharmaceutical companies?
Yes. Dr. Shi received a total of $14,227 from 36 companies across 699 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shi's costs compare to other endocrinologists in Burlingame?
Dr. Shi's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →